Research News

Research News | Jun. 03, 2013

Early Use of Hydroxychloroquine May Protect Against Organ Damage in Lupus

People with lupus who were treated with hydroxychloroquine (HCQ), an anti-malarial drug, early after a diagnosis of lupus had less cumulative organ damage at three years after diagnosis than those who did not receive HCQ, according to a new analysis.

Research News | Mar. 26, 2013

Increased Incidence of Shingles in People with Lupus

A study published in a recent issue of the journal Lupus reports that people with lupus had a 70 percent increased risk of developing shingles compared to participants without inflammatory disease.

Research News | Jan. 24, 2013

Protein Predicts Lupus-Related Organ Damage

A team of lupus researchers has identified a potential new biomarker that may be helpful in determining whether a person with lupus is at risk for developing organ damage.

Research News | Jan. 10, 2013

Study explores lupus treatments and disease activity as risk factors for lymphoma

A new study sheds light on the specific effects of drug treatments versus disease activity as risk factors for lymphoma, a type of cancer, among people with lupus.

Research News | Nov. 08, 2012

Steroid-Related Risk of Heart Disease in Lupus

The results of this study indicate that current use of steroids (20 mg/day or more) is perhaps the most significant risk factor for heart disease in individuals with lupus.

Research News | Nov. 08, 2012

Genetics of Lupus-Related Phenotypes

The researchers hoped to learn about the genetic contributions to lupus susceptibility and how this might relate to specific lupus-related phenotypes, such as the presence of specific autoantibodies.

Research News | Nov. 08, 2012

C-Reactive Protein as a Lupus Biomarker

The researchers hoped to learn about the relationship among hsCRP, lupus disease activity, and the risk of cardiovascular disease in individuals with lupus.

Research News | Oct. 16, 2012

Metabolic Syndrome Among People with Lupus

Metabolic syndrome is marked by increased risk of cardiovascular diseases, so its incidence among people with lupus can indicate risk of cardiovascular disease in lupus patients.